Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

137.22 +0.62 (+0.45%)

Streaming Delayed Price Updated: 11:37 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

CalSTRS Joins Politan Capital Management in Legal Action Against Masimo CEO’s Employment Agreement

March 03, 2023

From Politan Capital Management

Via Business Wire

Masimo to Present in 44th Annual Raymond James Institutional Investors Conference

March 02, 2023

From Masimo

Via Business Wire

Masimo Reports Fourth Quarter and Full-Year 2022 Financial Results

February 28, 2023

From Masimo

Via Business Wire

Analyst Says This MedTech Giant Stock Offers 'Too Much Optionality,' Upgrades Rating ↗

February 22, 2023

Via Benzinga

Expert Ratings for Masimo ↗

February 22, 2023

Via Benzinga

The Latest Analyst Ratings for Masimo ↗

January 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023 ↗

February 22, 2023

Via Benzinga

New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy

February 21, 2023

From Masimo

Via Business Wire

Masimo Centroid® Receives Innovative Technology Designation from Vizient

February 15, 2023

From Masimo

Via Business Wire

Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28

February 14, 2023

From Masimo

Via Business Wire

Thoughts For Thursday: Risk-off, Risk-on ↗

February 09, 2023

The one foot forward, one foot backward action continues on Wall Street, though yesterday it was more like three or four steps backward. It seems Q1 earnings jitters are responsible.

Via Talk Markets

NeurAxis: Should You Buy This IPO? ↗

February 08, 2023

As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype.

Via Talk Markets

Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)

January 30, 2023

From Masimo

Via Business Wire

Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

January 23, 2023

On Monday, Intuitive Surgical stock had its Relative Strength (RS) Rating upgraded to 81, up from 73 a day earlier.

Via Investor's Business Daily

InMode Stock Glowing Again As Cosmetic Surgery Market Recovers ↗

January 23, 2023

The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better.

Via Investor's Business Daily

Researchers Harness the Power of Masimo Root®’s Advanced Multimodal Monitoring Capabilities to Study the Impact of Different Ventilatory Strategies on Brain Oxygenation During Thoracoscopic Surgery

January 23, 2023

From Masimo

Via Business Wire

Masimo and Philips Expand Partnership to Improve Telehealth for Patients and Clinicians Around the World with the Masimo W1™ Watch

January 18, 2023

From Masimo

Via Business Wire

How Masimo Is Taking On Electronics Giant Apple — And Winning ↗

January 11, 2023

Apple could be on the hook for a royalty tied to its Apple Watch.

Via Investor's Business Daily

Apple Watch Faces Potential Import Ban As US Judge Rules Against Tech Giant In Patent Infringement Case ↗

January 10, 2023

Via Benzinga

ITC Judge Rules Apple Violated U.S. Trade Laws by Infringing Masimo Pulse Oximeter Patent

January 10, 2023

From Masimo

Via Business Wire

New Study Evaluates the Performance of Masimo SpHb® Noninvasive Spot-Check Hemoglobin in the Emergency Department

January 09, 2023

From Masimo

Via Business Wire

New Study Finds That Masimo Patient SafetyNet™ Helped Clinicians Reduce CPR Events and Rates, Improve CPR Success Rate, and Reduce Hospital Length of Stay and Mortality

January 05, 2023

From Masimo

Via Business Wire

Masimo to Present in 41st Annual J.P. Morgan Healthcare Conference

January 04, 2023

From Masimo

Via Business Wire

New Prospective Study Evaluates the Accuracy of Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring During Elective Cesarean Section

January 03, 2023

From Masimo

Via Business Wire

$7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying ↗

December 20, 2022

Although US stocks closed lower on Monday, there were a few notable insider trades.

Via Benzinga

Masimo Takes Major Step in Connecting the Hospital to the Home

December 13, 2022

From Masimo

Via Business Wire

Masimo Hosts Investor Day to Detail Next Phase of Its Growth Trajectory

December 13, 2022

From Masimo Corporation

Via Business Wire

Masimo Announces Limited Market Release of Sepsis Index

December 12, 2022

From Masimo

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022 ↗

December 15, 2022

Via Benzinga

Masimo Announces Full Market Release of Hydration Index for the Masimo W1™ Advanced Health Tracking Watch

December 07, 2022

From Masimo

Via Business Wire

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Masimo Corporation - Common Stock (NQ:MASI)

All News about Masimo Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today